EP1001777A4 - Fibrinogen-rezeptor-antagonisten - Google Patents

Fibrinogen-rezeptor-antagonisten

Info

Publication number
EP1001777A4
EP1001777A4 EP98935967A EP98935967A EP1001777A4 EP 1001777 A4 EP1001777 A4 EP 1001777A4 EP 98935967 A EP98935967 A EP 98935967A EP 98935967 A EP98935967 A EP 98935967A EP 1001777 A4 EP1001777 A4 EP 1001777A4
Authority
EP
European Patent Office
Prior art keywords
receptor antagonists
fibrinogen receptor
fibrinogen
antagonists
receptor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP98935967A
Other languages
English (en)
French (fr)
Other versions
EP1001777A1 (de
Inventor
Dirk Heerding
James M Samanen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Corp
Original Assignee
SmithKline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Corp filed Critical SmithKline Beecham Corp
Publication of EP1001777A1 publication Critical patent/EP1001777A1/de
Publication of EP1001777A4 publication Critical patent/EP1001777A4/de
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D211/62—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
EP98935967A 1997-07-25 1998-07-23 Fibrinogen-rezeptor-antagonisten Withdrawn EP1001777A4 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US5378897P 1997-07-25 1997-07-25
US53788P 1997-07-25
US6354597P 1997-10-28 1997-10-28
US63545P 1997-10-28
PCT/US1998/015288 WO1999004796A1 (en) 1997-07-25 1998-07-23 Fibrinogen receptor antagonists

Publications (2)

Publication Number Publication Date
EP1001777A1 EP1001777A1 (de) 2000-05-24
EP1001777A4 true EP1001777A4 (de) 2002-10-09

Family

ID=26732245

Family Applications (1)

Application Number Title Priority Date Filing Date
EP98935967A Withdrawn EP1001777A4 (de) 1997-07-25 1998-07-23 Fibrinogen-rezeptor-antagonisten

Country Status (6)

Country Link
EP (1) EP1001777A4 (de)
JP (1) JP2002509547A (de)
AU (1) AU8510398A (de)
CA (1) CA2297909A1 (de)
CO (1) CO4970784A1 (de)
WO (1) WO1999004796A1 (de)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997025323A1 (en) * 1996-01-11 1997-07-17 Smithkline Beecham Corporation Fibrinogen receptor antagonists

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997025323A1 (en) * 1996-01-11 1997-07-17 Smithkline Beecham Corporation Fibrinogen receptor antagonists

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO9904796A1 *

Also Published As

Publication number Publication date
WO1999004796A1 (en) 1999-02-04
JP2002509547A (ja) 2002-03-26
CO4970784A1 (es) 2000-11-07
CA2297909A1 (en) 1999-02-04
AU8510398A (en) 1999-02-16
EP1001777A1 (de) 2000-05-24

Similar Documents

Publication Publication Date Title
EP0912175A4 (de) Antagonisten des fibrinogenrezeptors
EP0810994A4 (de) Fibrinogen-rezeptor-antagonisten
HU9603525D0 (en) Vironectin receptor antagonists
EP1047425A4 (de) Integrinrezeptor antagonisten
EP0885205A4 (de) Fibrinogen-rezeptor-antagonisten
EP0866705A4 (de) Fibrinogenrezeptorantagonisten
GB9817910D0 (en) CCR-3 receptor antagonists
GB9405317D0 (en) Fibrinogen receptor antagonists
EP0885213A4 (de) Fibrinogenrezeptor antagonisten
EP1007051A4 (de) Integrin rezeptor antagonisten
EP0796098A4 (de) Fibrinogenrezeptor-antagonisten
EP0880511A4 (de) Integrin-rezeptor-antagonisten
IL135797A0 (en) Thrombin receptor antagonists
EP0801650A4 (de) Fibrinogenrezeptor-antagonisten
EP1027337A4 (de) Integrin-rezeptor-antagonisten
IL134301A0 (en) 2-acylaminopropanamines as tachykinin receptor antagonists
EP0794779A4 (de) Fibrinogenrezeptorantagonisten
GB9515852D0 (en) Fibrinogen receptor antagonists
EP1023295A4 (de) Prodrogen von fibrinogenrezeptor-antagonisten
IL134155A0 (en) 2-acylaminopropanamines as tachykinin receptor antagonists
EP0800395A4 (de) Antagonisten der fibrinogen-rezeptoren
EP0781133A4 (de) Fibrinogen-rezeptor-antagonisten
AU6826498A (en) Endotholin receptor antagonists
GB9516643D0 (en) Fibrinogen receptor antagonists
EP0957908A4 (de) Antagonisten des fibrinogen rezeptors

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20000117

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): BE CH DE ES FR GB IT LI NL

A4 Supplementary search report drawn up and despatched

Effective date: 20020826

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): BE CH DE ES FR GB IT LI NL

RIC1 Information provided on ipc code assigned before grant

Free format text: 7A 61K 31/495 A, 7C 07D 237/00 B, 7C 07D 211/62 B

17Q First examination report despatched

Effective date: 20040128

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20040508

REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1028552

Country of ref document: HK